Cargando…
Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With “Gray-Zone PSA” and Inhibits Cancer Progression via Regulating Glycosylation
BACKGROUND: This study aimed to explore the diagnostic value of alpha-l-fucosidase (AFU) in prostate cancer (PCa) patients with “gray-zone PSA” and to investigate the correlation between AFU expression and clinicopathological characteristics of PCa patients. METHODS: The level of AFU and other neces...
Autores principales: | Zhang, Cong, Liu, Jikai, Chao, Fan, Wang, Shiyu, Li, Dawei, Han, Dunsheng, Xu, Zhonghua, Xu, Guoxiong, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645591/ https://www.ncbi.nlm.nih.gov/pubmed/34881177 http://dx.doi.org/10.3389/fonc.2021.742354 |
Ejemplares similares
-
HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer
por: Wang, Shiyu, et al.
Publicado: (2021) -
The Emerging Role of Circular RNAs in Prostate Cancer: A Systematic Review
por: Chao, Fan, et al.
Publicado: (2021) -
Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?
por: Lee, Jaegeun, et al.
Publicado: (2021) -
The Value of Preoperative Alpha-L-Fucosidase Levels in Evaluation of Malignancy and Differential Diagnosis of Urothelial Neoplasms
por: Chen, Dongshan, et al.
Publicado: (2020) -
Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone
por: Liu, Junxiao, et al.
Publicado: (2020)